These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6426981)

  • 1. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of encainide (MJ9067) on canine subendocardial Purkinje fibers surviving infarction.
    King BW; Man RY
    J Cardiovasc Pharmacol; 1984; 6(4):547-54. PubMed ID: 6206306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological actions of flecainide in normal and infarcted canine Purkinje fibers.
    Kinnaird AA; Lederman CL; Man RY
    Eur J Pharmacol; 1985 May; 112(1):57-64. PubMed ID: 4018138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of lidocaine, l-chlorpheniramine, and bepridil on normal and ouabain-intoxicated canine Purkinje fibers.
    Kane KA; Berdeja García GY; Sánchez-Pérez S; Pastelín G
    J Cardiovasc Pharmacol; 1983; 5(1):109-15. PubMed ID: 6186844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of molecular form of local anesthetic-type antiarrhythmic agents on reduction of the maximum upstroke velocity of canine cardiac Purkinje fibers.
    Gintant GA; Hoffman BF; Naylor RE
    Circ Res; 1983 Jun; 52(6):735-46. PubMed ID: 6305532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dauricine and lidocaine alone or combined on electrophysiological properties of canine Purkinje fibers.
    Zhu JQ; Zeng FD; Hu CJ
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):220-5. PubMed ID: 2087994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on Ouabain-induced delayed afterdepolarizations in canine Purkinje fibers.
    Rosen MR; Danilo P
    Circ Res; 1980 Jan; 46(1):117-24. PubMed ID: 7349912
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
    Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA
    Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
    Pallandi RT; Campbell TJ
    Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers.
    Varro A; Nakaya Y; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1986; 8(1):178-85. PubMed ID: 2419682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tocainide on Purkinje fibers from normal and infarcted ventricular tissues.
    Dersham GH; Han J; Cameron JS; O'Connell DP
    J Electrocardiol; 1986 Oct; 19(4):355-9. PubMed ID: 3098883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of lidocaine on isolated guinea pig Purkinje fibers: comparison with its effects on papillary muscle.
    Aomine M
    Gen Pharmacol; 1989; 20(1):99-104. PubMed ID: 2707577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles.
    Oshita S; Sada H; Kojima M; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):67-82. PubMed ID: 6777703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of class I anti-arrhythmic drugs in infarcted tissue.
    Man RY; Bril A
    Clin Invest Med; 1991 Oct; 14(5):466-75. PubMed ID: 1742923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
    Spear JF; Moore EN
    Pacing Clin Electrophysiol; 1982 Mar; 5(2):238-50. PubMed ID: 6176964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.